Days At A Glance Speakers Session Type Search
Type

    08:50 - 09:00 
    Welcome
    Hall 2
    Mon 14 08:50
    Welcome
    Welcome
    09:00 - 09:40 
    Opening Keynote
    Hall 2
    Chair: Simon Pearce (Newcastle, United Kingdom)
    Mon 14 09:00
    PL1
    Opening Keynote
    Optimising Management of Adrenal Insufficiency
    Bergen, Norway
    09:45 - 11:15 
    Approaching Artificial Intelligence with... Intelligence.
    Meeting Room 2
    Chair: Kevin Murphy (London, United Kingdom) and Matthew Murphy (Cork, Ireland)
    Mon 14 09:45
    SK1.1
    Approaching Artificial Intelligence with... Intelligence.
    How to use AI for academic writing
    Derby, UK
    Mon 14 10:15
    SK1.2
    Approaching Artificial Intelligence with... Intelligence.
    Using AI to predict bone fractures
    Oxford, UK
    Mon 14 10:45
    Approaching Artificial Intelligence with... Intelligence.
    Open discussion
    Derby, UK
    Oxford, UK
    09:45 - 11:15 
    Reining in the Hyperactive Adrenal
    Meeting Room 3
    Chair: Conall Dennedy (Galway, Ireland) and Antoinette Tuthill (Cork, Ireland)
    Mon 14 09:45
    S1.1
    Reining in the Hyperactive Adrenal
    Mild autonomous cortisol secretion
    Sheffield, UK
    Mon 14 10:10
    S1.2
    Reining in the Hyperactive Adrenal
    Androgen excess
    Dublin, Ireland
    Mon 14 10:35
    S1.3
    Reining in the Hyperactive Adrenal
    The diagnostic approach to challenging adrenal lesions
    Glasgow, UK
    Mon 14 11:00
    OC1
    Reining in the Hyperactive Adrenal
    Oral Presentation: Differential tissue, and dose-specific adverse effects of exogenous glucocorticoids: implications for clinical practice
    Oxford, United Kingdom
    09:45 - 11:15 
    How Do I?...1: Diabetes
    Hall 2
    Chair: Helen Wallace (Belfast, Ireland) and Mairead Crowley (Dublin, Ireland)
    Mon 14 09:45
    HD1.1
    How Do I?...1: Diabetes
    How do I manage NG feeding-related hyperglycemia
    Limerick, Ireland
    Mon 14 10:00
    HDI1.2
    How Do I?...1: Diabetes
    How do I manage diabetes across time zones?
    Galway, Ireland
    Mon 14 10:15
    HDI1.3
    How Do I?...1: Diabetes
    How do I counsel my patient with diabetes on driving regulations
    Waterford, Ireland
    Mon 14 10:30
    HDI1.4
    How Do I?...1: Diabetes
    How do I manage severe hypertriglyceridaemia?
    Belfast , Ireland
    Mon 14 10:45
    HDI1.6
    How Do I?...1: Diabetes
    How do I approach diabetes distress?
    Belfast , Ireland
    Mon 14 11:00
    HDI1.5
    How Do I?...1: Diabetes
    Managing Frailty in Older People with Diabetes
    London, UK
    11:20 - 12:20 
    An MDT approach to NETs
    Meeting Room 2
    Chair: Ruth Casey (Cambridge, UK) and Anne Marie Hannon (Limerick, Ireland)
    Mon 14 11:20
    S2.1
    An MDT approach to NETs
    PRRT in treatment algorithims for Gastrenteropancreatic NETs
    Sheffield, United Kingdom
    Mon 14 11:50
    S2.2
    An MDT approach to NETs
    Managing secretory NETs
    Dublin, Ireland
    11:20 - 12:20 
    Case Reports from submitted abstracts
    Hall 2
    Chair: Miles Levy (Leicester, United Kingdom) and Kevin Moore (Naas, Ireland)
    Mon 14 11:20
    CR1
    Case Reports from submitted abstracts
    Refractory Hypercalcaemia in Advanced Metastatic Pancreatic Neuroendocrine Tumour Controlled on Weekly Denosumab
    Sheffield, United Kingdom
    Mon 14 11:30
    CR2
    Case Reports from submitted abstracts
    Use of radiofrequency ablation(RFA) in the management of thyroid nodules – a single centre experience
    Dublin, Ireland
    Mon 14 11:40
    CR3
    Case Reports from submitted abstracts
    Adrenocorticotropin (ACTH) independent Cushing’s Syndrome in pregnancy secondary to overproduction of adrenal luteinizing hormone/human chorionic gonadotropins receptors.
    Islamabad, Pakistan
    Mon 14 11:50
    CR4
    Case Reports from submitted abstracts
    Pregnancy induction with pulsatile gonadotropin releasing hormone pump (GNRH) therapy in a patient with a KISS1 receptor mutation associated normosmic congenital hypogonadotropic hypogonadism and a very low anti-mullerian hormone: A Case Study
    Cork, Ireland
    Mon 14 12:00
    CR5
    Case Reports from submitted abstracts
    Gastrointestinal Morbidity Related to Delayed Diagnosis of Pheochromocytoma
    Wolverhampton, United Kingdom
    Mon 14 12:10
    CR6
    Case Reports from submitted abstracts
    GLP1 receptor agonist and sulphonylurea treatment in KCNJ11 Permanent Neonatal Diabetes
    Dublin, Ireland
    11:20 - 12:20 
    Navigating UK/Irish Training for International Graduates
    Meeting Room 3
    Chair: Fidelma Dunne (Galway, Ireland) and Kashyap Patel (Exeter, United Kingdom)
    Mon 14 11:20
    T1.1
    Navigating UK/Irish Training for International Graduates
    International Graduates in the UK health service – facts and figures
    Coventry, UK
    Mon 14 11:35
    T1.2
    Navigating UK/Irish Training for International Graduates
    How to work effectively in a UK/Irish MDT
    London, United Kingdom
    Mon 14 11:50
    T1.3
    Navigating UK/Irish Training for International Graduates
    What I wish I’d known - Starting in a new country as an international medical graduate
    Dublin, Ireland
    Mon 14 12:05
    Navigating UK/Irish Training for International Graduates
    Panel Discussion
    12:20 - 13:35 
    Lunch, Exhibition and Posters
    Hall 1
    12:25 - 13:00 
    Oral Posters - Endocrinology 1
    Hall 2
    Chair: Mark Hannon (Bantry, Ireland) and Maralyn Druce (London, United Kingdom)
    Mon 14 12:25
    OP1
    Oral Posters - Endocrinology 1
    Gene methylation status in delayed puberty
    London, United Kingdom
    Mon 14 12:33
    OP2
    Oral Posters - Endocrinology 1
    Audit on the Management of Cystic Prolactinomas
    Dublin, Ireland
    Mon 14 12:41
    OP3
    Oral Posters - Endocrinology 1
    Immunomodulation of Severe Graves' Disease: Graves'-Plasma Cell Depletion (PCD) Trial
    Newcastle, United Kingdom
    Mon 14 12:49
    OP4
    Oral Posters - Endocrinology 1
    GIP receptor agonist and antagonist alter testicular morphology and sperm parameters in high-fat diet fed obese mice.
    Coleraine, United Kingdom
    12:35 - 13:35 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA 1 - (Please see Sponsored Satellite Symposia programme for more information)
    Meeting Room 2
    12:35 - 13:35 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA 2 - (Please see Sponsored Satellite Symposia programme for more information)
    Meeting Room 3
    13:00 - 13:35 
    Oral Posters - Diabetes, Obesity and Metabolism 1
    Hall 2
    Chair: Oratile Kgosidialwa (Cork, Ireland) and Robert Murray (Leeds, United Kingdom)
    Mon 14 13:00
    OP5
    Oral Posters - Diabetes, Obesity and Metabolism 1
    The role of soluble epoxide hydrolase in metabolic-associated fatty liver disease.
    Taipei, Taiwan
    Mon 14 13:08
    OP6
    Oral Posters - Diabetes, Obesity and Metabolism 1
    11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependent
    Leeds, United Kingdom
    Mon 14 13:16
    OP7
    Oral Posters - Diabetes, Obesity and Metabolism 1
    Hybrid acylated and non-acylated GLP-1 and apelin receptor co-agonist peptides, show promising acute in vivo anti-hyperglycaemic actions in normal healthy and insulin resistant diet-induced obese mice.
    Coleraine, United Kingdom
    Mon 14 13:24
    OP8
    Oral Posters - Diabetes, Obesity and Metabolism 1
    Immunophilin Protein FKBPL Regulates Body Weight, Glucose Tolerance, and Islet Morphology in Mice Independent of Food Intake
    Dublin, Ireland
    13:40 - 14:00 
    Society for Endocrinology Oral Plenary 1
    Hall 2
    Chair: Mark Gurnell (Cambridge, United Kingdom) and Fidelma Dunne (Galway, Ireland)
    Mon 14 13:40
    PLO1
    Society for Endocrinology Oral Plenary 1
    Damaging mutations in LXRα uncouple lipogenesis from hepatotoxicity and implicate hepatic cholesterol sensing in human liver health
    Cambridge, United Kingdom
    14:00 - 14:30 
    Plenary
    Hall 2
    Chair: Mark Gurnell (Cambridge, United Kingdom)
    Mon 14 14:00
    P2
    Plenary
    Acromegaly is a metabolic disease, far more than a pituitary one
    Erasmus University MC, The Netherlands
    14:35 - 16:05 
    Bone Update
    Meeting Room 3
    Chair: Maeve Durkan (Cork, Ireland) and Caroline Gorvin (Birmingham, United Kingdom)
    Mon 14 14:35
    S3.1
    Bone Update
    Effects of Exercise on Bone
    Loughborough , UK
    Mon 14 15:00
    S3.2
    Bone Update
    Gut-Derived Peptides and Bone Disorders in Obesity and Diabetes
    Ulster , Ireland
    Mon 14 15:25
    S3.3
    Bone Update
    Identification of the genetic determinants and clinical implications of bone marrow adiposity using deep learning in the UK Biobank
    Edinburgh , Scotland
    Mon 14 15:50
    OC2
    Bone Update
    Oral Presentation: The orphan G protein-coupled receptor 35 (GPR35) has an antiresorptive role in primary human osteoclasts
    Birmingham, United Kingdom
    14:35 - 16:05 
    Genetics in Endocrinology
    Meeting Room 2
    Chair: Paula O Shea (Dublin, Ireland) and Robert Semple (Edinburgh, United Kingdom)
    Mon 14 14:35
    SK2.1
    Genetics in Endocrinology
    Hereditary Endocrine neoplasia
    Cambridge, United Kingdom
    Mon 14 15:05
    SK2.2
    Genetics in Endocrinology
    Phenotype-First or Genotype-First in Genomic Sequencing: What It Means for Clinicians
    Exeter, UK
    Mon 14 15:35
    SK2.3
    Genetics in Endocrinology
    Hereditary pituitary disease
    London, UK
    14:35 - 16:05 
    Type 1 Diabetes
    Hall 2
    Chair: Neil Black (Londonderry, Ireland) and (Tomas Griffin (Galway, Ireland)
    Mon 14 14:35
    S4.1
    Type 1 Diabetes
    Hybrid closed loop technology
    Dublin, Republic of Ireland
    Mon 14 15:00
    S4.2
    Type 1 Diabetes
    T1DM & Exercise
    Exeter, United Kingdom
    Mon 14 15:25
    S4.3
    Type 1 Diabetes
    Hypoglycaemia - in the age of CGM
    Dublin, Ireland
    Mon 14 15:50
    OC3
    Type 1 Diabetes
    Oral Presentation: The relation of microvascular complications to a new interpretation of glycaemic variability from continuous glucose monitoring in people with type 1 diabetes (T1D)
    Salford, United Kingdom
    16:05 - 16:30 
    Tea and Coffee
    Hall 1
    16:30 - 17:30 
    Obesity
    Hall 2
    Chair: Jean O'Connell (Dublin, Ireland) and Sam Lockhart (Cambridge, United Kingdom)
    Mon 14 16:30
    S6.1
    Obesity
    Metabolic Surgery which to choose and new developments
    Dublin, Ireland
    Mon 14 16:55
    S6.2
    Obesity
    Medical therapies in practice and new developments
    Belfast, Ireland
    Mon 14 17:20
    OC4
    Obesity
    Oral Presentation: Selective sweep mapping identifies obesity candidate mutations in Labrador Retrievers
    Cambridge, United Kingdom
    16:30 - 17:30 
    A beginners guide to translational research
    Meeting Room 2
    Chair: Diarmuid Smith (Dublin, Ireland) and Waljit Dhillo (London, United Kingdom)
    Mon 14 16:30
    SK3.1
    A beginners guide to translational research
    Using the integration of omic data to predict and model endocrine action
    Manchester, United Kingdom
    Mon 14 17:00
    SK3.2
    A beginners guide to translational research
    How do I design a clinical trial?
    Galway, Ireland
    16:30 - 17:30 
    Tricky Pituitary Cases
    Meeting Room 3
    Chair: Domhnall O'Halloran (Cork, Ireland) and Bahram Jafar-Mohammadi (Oxford, United Kingdom)
    Mon 14 16:30
    S7.1
    Tricky Pituitary Cases
    Other sellar tumours
    London, UK
    Mon 14 16:55
    S7.2
    Tricky Pituitary Cases
    Cyclical Cushing's
    Tartu, Estonia
    Mon 14 17:20
    OC5
    Tricky Pituitary Cases
    Oral Presentation: Multiplex Immunofluorescence Identifies Novel Role for STING Upregulation in Pituitary Neuroendocrine Tumours
    Belfast, United Kingdom
    17:30 - 18:00 
    Irish Endocrine Society: Hadden Lecture
    Hall 2
    Chair: Fidelma Dunne (Galway, Ireland)
    Mon 14 17:30
    PL3
    Irish Endocrine Society: Hadden Lecture
    The endocrinologist’s role along the patient cancer journey – from pre-diagnosis to survival and vitality beyond
    London, UK
    18:00 - 18:30 
    Diabetes & Metabolism Plenary
    Hall 2
    Chair: Ridhwaan Salemohamed (Galway, Ireland)
    Mon 14 18:00
    PL4
    Diabetes & Metabolism Plenary
    Leveraging Insights into Type 1 Diabetes Pathogenesis from Rare Human Pancreas Biobanks
    Exeter, UK
    18:30 - 19:10 
    Networking Reception
    Hall 1
    19:30 - 23:59 
    Conference Dinner

    08:00 - 09:00 
    Irish Endocrine Society: AGM
    Meeting Room 2
    08:00 - 09:00 
    Society for Endocrinology: AGM
    Meeting Room 3
    09:00 - 09:30 
    Irish Endocrine Society: McKenna Lecture
    Hall 2
    Chair: Fidelma Dunne (Galway, Ireland)
    Tue 15 09:00
    PL5
    Irish Endocrine Society: McKenna Lecture
    When “the best laid schemes of mice and men go oft awry.”
    Galway, Ireland
    09:30 - 10:00 
    Endocrinology Plenary
    Hall 2
    Chair: Rachel Crowley (Dublin, Ireland)
    Tue 15 09:30
    PL6
    Endocrinology Plenary
    State of the Art in Osteoporosis
    Aarhus, Denmark
    10:00 - 10:15 
    Tea and Coffee
    Hall 1
    10:15 - 12:00 
    Emerging Best Practice in Thyroid Disease
    Meeting Room 3
    Chair: Elizabeth Brosnan (Castlebar, Ireland) and Bijay Vaidya (Exeter, United Kingdom)
    Tue 15 10:15
    S8.1
    Emerging Best Practice in Thyroid Disease
    Current Management of Low Risk Thyroid Cancer
    Birmingham, UK
    Tue 15 10:45
    S8.2
    Emerging Best Practice in Thyroid Disease
    Safe Treatment of Thyroid Disease in Pregnancy
    Dublin, Ireland
    Tue 15 11:15
    S8.3
    Emerging Best Practice in Thyroid Disease
    Natural history and management of thyroid hormone resistance-beta: what can real-World data tell us?
    Cardiff University, United Kingdom
    Tue 15 11:45
    OC7
    Emerging Best Practice in Thyroid Disease
    Oral Presentation: Thyroid Hormone analogue (Triac) therapy in Resistance to Thyroid Hormone beta reduces hyperthyroid symptoms, lowers circulating thyroid hormones and metabolic rate effectively, without adverse effects.
    Dublin, Ireland
    10:15 - 12:00 
    PCOS across lifespan
    Meeting Room 2
    Chair: Lisa Owens (Dublin, Ireland) and Punith Kempegowda (Birmingham, United Kingdom)
    Tue 15 10:15
    S10.1
    PCOS across lifespan
    Metabolic and Cardiovascular consequences (North Finland Cohort)
    Oulu, Finland
    Tue 15 10:45
    S10.2
    PCOS across lifespan
    Expanding diagnostic and biochemical aspects of PCOS
    Birmingham, UK
    Tue 15 11:15
    S10.3
    PCOS across lifespan
    Fertility treatment and pre-conception optimisation
    Dublin, Ireland
    Tue 15 11:45
    OC8
    PCOS across lifespan
    Oral Presentation: Investigation of the differential impact of oral classic and 11-oxygenated androgen precursor administration on downstream androgen metabolism and insulin sensitivity in women with polycystic ovary syndrome (PCOS)
    Dublin, Ireland
    10:15 - 12:00 
    Type 2 Diabetes
    Hall 2
    Chair: Eoin Noctor (Limerick, Ireland) and Chioma Izzi-Engbeaya (London, United Kingdom)
    Tue 15 10:15
    S9.1
    Type 2 Diabetes
    Exercise and type 2 diabetes: can we predict changes in glycaemic control and weight during training?
    Glasgow , Scotland
    Tue 15 10:45
    S9.2
    Type 2 Diabetes
    Community Diabetes - setting up a service/ Value based health care
    Belfast, Ireland
    Tue 15 11:15
    S9.3
    Type 2 Diabetes
    Using healthcare data to improve practice and yield disease insights
    Edinburgh, Scotland
    Tue 15 11:45
    OC6
    Type 2 Diabetes
    Oral Presentation: Once-daily oral administration of gpr55 agonist ml-184 has direct and indirect benefits on β-cell and gastrointestinal health in obese-diabetic mice
    Coleraine, United Kingdom
    12:00 - 13:15 
    Lunch, Exhibition and Posters
    Hall 1
    12:05 - 12:40 
    Oral Posters - Diabetes, Obesity and Metabolism 2
    Hall 2
    Chair: Robert McEvoy (Galway, Ireland) and Maryjane Brassill (Tipperary, Ireland)
    Tue 15 12:05
    OP9
    Oral Posters - Diabetes, Obesity and Metabolism 2
    The impact of social deprivation on development and progression of diabetic kidney disease- a retrospective cohort study
    Galway, Ireland
    Tue 15 12:13
    Oral Posters - Diabetes, Obesity and Metabolism 2
    Access to Psychological Medicine Services improves outcomes in vulnerable patients with diabetes
    Dublin, Ireland
    Tue 15 12:21
    OP11
    Oral Posters - Diabetes, Obesity and Metabolism 2
    Associations between Fear of Hypoglycaemia and Step-Count Among Adults with Type 1 Diabetes and Insulin-Treated Type 2 Diabetes: Findings from the Hypo-METRICS Study
    Belfast, United Kingdom
    Tue 15 12:29
    OP12
    Oral Posters - Diabetes, Obesity and Metabolism 2
    Real-world outcomes of smart insulin pens in adults with diabetes mellitus attending an Irish tertiary hospital
    Dublin, Ireland
    12:15 - 13:15 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA 3 - (Please see Sponsored Satellite Symposia programme for more information)
    Meeting Room 2
    12:15 - 13:15 
    INDUSTRY-SPONSORED SATELLITE SYMPOSIA 4 - (Please see Sponsored Satellite Symposia programme for more information)
    Meeting Room 3
    12:40 - 13:15 
    Oral Posters - Endocrinology 2
    Hall 2
    Chair: Ronan Canavan (Dublin, Ireland) and Jeremy Turner (Norfolk, United Kingdom)
    Tue 15 12:40
    OP13
    Oral Posters - Endocrinology 2
    A tiered, evidence-based approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency
    London, United Kingdom
    Tue 15 12:48
    OP14
    Oral Posters - Endocrinology 2
    Bone fragility and beyond: prevalence and impact of clinical signs, symptoms, and events in children with osteogenesis imperfecta
    Oxford, United Kingdom
    Tue 15 12:56
    OP15
    Oral Posters - Endocrinology 2
    A UK single-centre experience of the use of osilodrostat in pituitary MRI negative Cushing’s Disease
    London, United Kingdom
    Tue 15 13:04
    OP16
    Oral Posters - Endocrinology 2
    Investigating Metastatic Potential in Papillary Thyroid Microcarcinoma (PTMC).
    Cork, Ireland
    13:20 - 14:50 
    How Do I? 2: Endocrinology
    Hall 2
    Chair: Amar Agha (Dublin, Ireland) and Victoria Stokes (Cambridge, United Kingdom)
    Tue 15 13:20
    HDI2.1
    How Do I? 2: Endocrinology
    How do I use co-peptin and hypertonic saline in AVP disorders?
    Tue 15 13:35
    HDI2.2
    How Do I? 2: Endocrinology
    How do I treat psychiatric complications of Cushing's syndrome?
    Birmingham, UK
    Tue 15 13:50
    HDI2.3
    How Do I? 2: Endocrinology
    How do I prepare the complex thyrotoxic patient with cardiac disease for surgery?
    Dublin, Ireland
    Tue 15 14:05
    HDI2.4
    How Do I? 2: Endocrinology
    How do I medically manage primary hyperaldosteronism?
    Cambridge, UK
    Tue 15 14:20
    HDI2.5
    How Do I? 2: Endocrinology
    How do I manage menopause without HRT?
    London, UK
    Tue 15 14:35
    HDI2.6
    How Do I? 2: Endocrinology
    How do I select and prepare a patient for parathyroid surgery?
    Galway, Ireland
    13:20 - 14:50 
    Managing Hypothalamic Syndromes
    Meeting Room 2
    Chair: Nigel Glynn (Dublin, Ireland) and Andrew Lansdown (Cardiff, United Kingdom)
    Tue 15 13:20
    S12.1
    Managing Hypothalamic Syndromes
    Disordered sleep
    Dublin, Ireland
    Tue 15 13:45
    S12.2
    Managing Hypothalamic Syndromes
    Water balance
    Dublin, Ireland
    Tue 15 14:10
    S12.3
    Managing Hypothalamic Syndromes
    Unravelling Hypothalamic Obesity: Navigating the Challenges and Exploring Future Solutions
    Sheffield, UK
    Tue 15 14:35
    OC10
    Managing Hypothalamic Syndromes
    Oral Presentation: Gonadotropin Rise Following Intranasal Kisspeptin Administration Is Increased in Women With Hypothalamic Amenorrhoea Compared to Healthy Women
    London, United Kingdom
    13:20 - 14:50 
    Diabetes in Pregnancy
    Meeting Room 3
    Chair: Christine Newman (Galway, Ireland) and Kleopatra Alexiadou (London, United Kingdom)
    Tue 15 13:20
    S11.1
    Diabetes in Pregnancy
    T2 in pregnancy
    Aarhus , Denmark
    Tue 15 13:45
    S11.2
    Diabetes in Pregnancy
    Technology in pregnancy
    Cambridge, UK
    Tue 15 14:10
    S11.3
    Diabetes in Pregnancy
    Metformin in pregnancy complicated by diabetes
    Galway, Ireland
    Tue 15 14:35
    OC9
    Diabetes in Pregnancy
    Oral Presentation: Pregnancy induced pancreatic islet expansion is compromised by consumption of cafeteria diet
    Coleraine, United Kingdom
    14:55 - 15:15 
    Society for Endocrinology Oral Plenary 2
    Hall 2
    Chair: Robert Semple (Edinburgh, United Kingdom) and Fidelma Dunne (Galway, Ireland)
    Tue 15 14:55
    PLO2
    Society for Endocrinology Oral Plenary 2
    Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Enabled Glucocorticoid Dose Reductions in Adults with Classic Congenital Adrenal Hyperplasia: Results from CAHtalyst™
    London, United Kingdom
    15:15 - 15:55 
    Closing Keynote
    Hall 2
    Chair: Robert Semple (Edinburgh, United Kingdom)
    Tue 15 15:15
    PL7
    Closing Keynote
    Island Hopping: Adventures in Hormones, Metabolism and Behaviour
    Cambridge, UK
    15:55 - 16:15 
    Prizes and Close
    Hall 2
    Chair: Márta Korbonits (London, UK) and Fidelma Dunne (Galway, Ireland)
Prof Rob Andrews
Exeter, United Kingdom
Mon 14 15:00
S4.2
Type 1 Diabetes
T1DM & Exercise
Exeter, United Kingdom
Riikka Arffman
Oulu, Finland
Tue 15 10:15
S10.1
PCOS across lifespan
Metabolic and Cardiovascular consequences (North Finland Cohort)
Oulu, Finland
Lucy-Ann  Behan
Dublin, Ireland
Tue 15 11:15
S10.3
PCOS across lifespan
Fertility treatment and pre-conception optimisation
Dublin, Ireland
Dr Marcia  Bell
Galway, Ireland
Tue 15 14:35
HDI2.6
How Do I? 2: Endocrinology
How do I select and prepare a patient for parathyroid surgery?
Galway, Ireland
Kristien Boelaert
Birmingham, UK
Tue 15 10:15
S8.1
Emerging Best Practice in Thyroid Disease
Current Management of Low Risk Thyroid Cancer
Birmingham, UK
Dr Katherine  Brooke-Wavell
Loughborough , UK
Mon 14 14:35
S3.1
Bone Update
Effects of Exercise on Bone
Loughborough , UK
Brian Carthy
Cork, Ireland
Mon 14 11:50
CR4
Case Reports from submitted abstracts
Pregnancy induction with pulsatile gonadotropin releasing hormone pump (GNRH) therapy in a patient with a KISS1 receptor mutation associated normosmic congenital hypogonadotropic hypogonadism and a very low anti-mullerian hormone: A Case Study
Cork, Ireland
Ruth Casey
Cambridge, United Kingdom
Mon 14 14:35
SK2.1
Genetics in Endocrinology
Hereditary Endocrine neoplasia
Cambridge, United Kingdom
Caoimhe Casey
Galway, Ireland
Tue 15 12:05
OP9
Oral Posters - Diabetes, Obesity and Metabolism 2
The impact of social deprivation on development and progression of diabetic kidney disease- a retrospective cohort study
Galway, Ireland
Dr William Cawthorn
Edinburgh , Scotland
Mon 14 15:25
S3.3
Bone Update
Identification of the genetic determinants and clinical implications of bone marrow adiposity using deep learning in the UK Biobank
Edinburgh , Scotland
Justine Tin Nok Chan
Cambridge, United Kingdom
Mon 14 17:20
OC4
Obesity
Oral Presentation: Selective sweep mapping identifies obesity candidate mutations in Labrador Retrievers
Cambridge, United Kingdom
Professor  Helen  Colhoun
Edinburgh, Scotland
Tue 15 11:15
S9.3
Type 2 Diabetes
Using healthcare data to improve practice and yield disease insights
Edinburgh, Scotland
Saidhbh Comerford
Dublin, Ireland
Tue 15 12:13
Oral Posters - Diabetes, Obesity and Metabolism 2
Access to Psychological Medicine Services improves outcomes in vulnerable patients with diabetes
Dublin, Ireland
Reece Corbett
Coleraine, United Kingdom
Tue 15 11:45
OC6
Type 2 Diabetes
Oral Presentation: Once-daily oral administration of gpr55 agonist ml-184 has direct and indirect benefits on β-cell and gastrointestinal health in obese-diabetic mice
Coleraine, United Kingdom
Aoife Courtney
Dublin, Ireland
Tue 15 12:29
OP12
Oral Posters - Diabetes, Obesity and Metabolism 2
Real-world outcomes of smart insulin pens in adults with diabetes mellitus attending an Irish tertiary hospital
Dublin, Ireland
Mairéad Crowley
Dublin, Ireland
Mon 14 12:10
CR6
Case Reports from submitted abstracts
GLP1 receptor agonist and sulphonylurea treatment in KCNJ11 Permanent Neonatal Diabetes
Dublin, Ireland
Dr Rachel Crowley
Dublin, Ireland
Tue 15 13:20
S12.1
Managing Hypothalamic Syndromes
Disordered sleep
Dublin, Ireland
Aine   Cunningham
Galway, Ireland
Mon 14 10:00
HDI1.2
How Do I?...1: Diabetes
How do I manage diabetes across time zones?
Galway, Ireland
Dr Mark  Davies
Belfast , Ireland
Mon 14 10:45
HDI1.6
How Do I?...1: Diabetes
How do I approach diabetes distress?
Belfast , Ireland
Professor  Miguel DeBono
Sheffield, UK
Mon 14 09:45
S1.1
Reining in the Hyperactive Adrenal
Mild autonomous cortisol secretion
Sheffield, UK
Professor  Paul Dimitri
Sheffield, UK
Tue 15 14:10
S12.3
Managing Hypothalamic Syndromes
Unravelling Hypothalamic Obesity: Navigating the Challenges and Exploring Future Solutions
Sheffield, UK
Dr Patrick Divilly
Dublin, Ireland
Mon 14 15:25
S4.3
Type 1 Diabetes
Hypoglycaemia - in the age of CGM
Dublin, Ireland
Dr James Dorling
Glasgow , Scotland
Tue 15 10:15
S9.1
Type 2 Diabetes
Exercise and type 2 diabetes: can we predict changes in glycaemic control and weight during training?
Glasgow , Scotland
Professor William Drake
London, UK
Mon 14 16:30
S7.1
Tricky Pituitary Cases
Other sellar tumours
London, UK
Maralyn Druce
London, UK
Mon 14 17:30
PL3
Irish Endocrine Society: Hadden Lecture
The endocrinologist’s role along the patient cancer journey – from pre-diagnosis to survival and vitality beyond
London, UK
Professor  Fidelma Dunne
Galway, Ireland
Tue 15 14:10
S11.3
Diabetes in Pregnancy
Metformin in pregnancy complicated by diabetes
Galway, Ireland
Dr Hannah Forde
Dublin, Republic of Ireland
Mon 14 14:35
S4.1
Type 1 Diabetes
Hybrid closed loop technology
Dublin, Republic of Ireland
Marie Freel
Glasgow, UK
Mon 14 10:35
S1.3
Reining in the Hyperactive Adrenal
The diagnostic approach to challenging adrenal lesions
Glasgow, UK
Edouard G Mills
London, United Kingdom
Tue 15 14:35
OC10
Managing Hypothalamic Syndromes
Oral Presentation: Gonadotropin Rise Following Intranasal Kisspeptin Administration Is Increased in Women With Hypothalamic Amenorrhoea Compared to Healthy Women
London, United Kingdom
Lydia Grixti
Newcastle, United Kingdom
Mon 14 12:41
OP3
Oral Posters - Endocrinology 1
Immunomodulation of Severe Graves' Disease: Graves'-Plasma Cell Depletion (PCD) Trial
Newcastle, United Kingdom
Mark Gurnell
Cambridge, UK
Tue 15 14:05
HDI2.4
How Do I? 2: Endocrinology
How do I medically manage primary hyperaldosteronism?
Cambridge, UK
Charlotte L Hall
London, United Kingdom
Mon 14 12:25
OP1
Oral Posters - Endocrinology 1
Gene methylation status in delayed puberty
London, United Kingdom
Joyce  Harper
London, UK
Tue 15 14:20
HDI2.5
How Do I? 2: Endocrinology
How do I manage menopause without HRT?
London, UK
Adrian Heald
Salford, United Kingdom
Mon 14 15:50
OC3
Type 1 Diabetes
Oral Presentation: The relation of microvascular complications to a new interpretation of glycaemic variability from continuous glucose monitoring in people with type 1 diabetes (T1D)
Salford, United Kingdom
Helen  Heneghan
Dublin, Ireland
Mon 14 16:30
S6.1
Obesity
Metabolic Surgery which to choose and new developments
Dublin, Ireland
Zin Htut
London, United Kingdom
Mon 14 11:35
T1.2
Navigating UK/Irish Training for International Graduates
How to work effectively in a UK/Irish MDT
London, United Kingdom
Tue 15 12:56
OP15
Oral Posters - Endocrinology 2
A UK single-centre experience of the use of osilodrostat in pituitary MRI negative Cushing’s Disease
London, United Kingdom
Professor  Eystein Husebye
Bergen, Norway
Mon 14 09:00
PL1
Opening Keynote
Optimising Management of Adrenal Insufficiency
Bergen, Norway
Prof Nigel  Irwin
Ulster , Ireland
Mon 14 15:00
S3.2
Bone Update
Gut-Derived Peptides and Bone Disorders in Obesity and Diabetes
Ulster , Ireland
Dr Kristina  Isand
Tartu, Estonia
Mon 14 16:55
S7.2
Tricky Pituitary Cases
Cyclical Cushing's
Tartu, Estonia
Misbah Jabeen
Islamabad, Pakistan
Mon 14 11:40
CR3
Case Reports from submitted abstracts
Adrenocorticotropin (ACTH) independent Cushing’s Syndrome in pregnancy secondary to overproduction of adrenal luteinizing hormone/human chorionic gonadotropins receptors.
Islamabad, Pakistan
Professsor  Kassim	 Javaid
Oxford, UK
Mon 14 10:15
SK1.2
Approaching Artificial Intelligence with... Intelligence.
Using AI to predict bone fractures
Oxford, UK
Mon 14 10:45
Approaching Artificial Intelligence with... Intelligence.
Open discussion
Derby, UK
Oxford, UK
Professor  Ulla  Kampmann
Aarhus , Denmark
Tue 15 13:20
S11.1
Diabetes in Pregnancy
T2 in pregnancy
Aarhus , Denmark
Niki Karavitaki
Birmingham, UK
Tue 15 13:35
HDI2.2
How Do I? 2: Endocrinology
How do I treat psychiatric complications of Cushing's syndrome?
Birmingham, UK
Manjeet Kaur Sehemby
Wolverhampton, United Kingdom
Mon 14 12:00
CR5
Case Reports from submitted abstracts
Gastrointestinal Morbidity Related to Delayed Diagnosis of Pheochromocytoma
Wolverhampton, United Kingdom
Dawood Khan
Coleraine, United Kingdom
Mon 14 12:49
OP4
Oral Posters - Endocrinology 1
GIP receptor agonist and antagonist alter testicular morphology and sperm parameters in high-fat diet fed obese mice.
Coleraine, United Kingdom
Professor Márta Korbonits
London, UK
Mon 14 15:35
SK2.3
Genetics in Endocrinology
Hereditary pituitary disease
London, UK
Rama Lakshman
Belfast, United Kingdom
Tue 15 12:21
OP11
Oral Posters - Diabetes, Obesity and Metabolism 2
Associations between Fear of Hypoglycaemia and Step-Count Among Adults with Type 1 Diabetes and Insulin-Treated Type 2 Diabetes: Findings from the Hypo-METRICS Study
Belfast, United Kingdom
Professor Bente Langdahl
Aarhus, Denmark
Tue 15 09:30
PL6
Endocrinology Plenary
State of the Art in Osteoporosis
Aarhus, Denmark
Pin-Hsuan Li
Taipei, Taiwan
Mon 14 13:00
OP5
Oral Posters - Diabetes, Obesity and Metabolism 1
The role of soluble epoxide hydrolase in metabolic-associated fatty liver disease.
Taipei, Taiwan
Sam Lockhart
Cambridge, United Kingdom
Mon 14 13:40
PLO1
Society for Endocrinology Oral Plenary 1
Damaging mutations in LXRα uncouple lipogenesis from hepatotoxicity and implicate hepatic cholesterol sensing in human liver health
Cambridge, United Kingdom
Ee Wen Loh
Sheffield, United Kingdom
Mon 14 11:20
CR1
Case Reports from submitted abstracts
Refractory Hypercalcaemia in Advanced Metastatic Pancreatic Neuroendocrine Tumour Controlled on Weekly Denosumab
Sheffield, United Kingdom
Paul Benjamin Loughrey
Belfast, United Kingdom
Mon 14 17:20
OC5
Tricky Pituitary Cases
Oral Presentation: Multiplex Immunofluorescence Identifies Novel Role for STING Upregulation in Pituitary Neuroendocrine Tumours
Belfast, United Kingdom
Stephen Ludgate
Dublin, Ireland
Mon 14 11:30
CR2
Case Reports from submitted abstracts
Use of radiofrequency ablation(RFA) in the management of thyroid nodules – a single centre experience
Dublin, Ireland
Glynis  Magee
Belfast, Ireland
Tue 15 10:45
S9.2
Type 2 Diabetes
Community Diabetes - setting up a service/ Value based health care
Belfast, Ireland
Julie Martin Grace
Dublin, Ireland
Tue 15 11:45
OC7
Emerging Best Practice in Thyroid Disease
Oral Presentation: Thyroid Hormone analogue (Triac) therapy in Resistance to Thyroid Hormone beta reduces hyperthyroid symptoms, lowers circulating thyroid hormones and metabolic rate effectively, without adverse effects.
Dublin, Ireland
Darran Mc Donald
Dublin, Ireland
Mon 14 12:33
OP2
Oral Posters - Endocrinology 1
Audit on the Management of Cystic Prolactinomas
Dublin, Ireland
Mark McCarthy
Cork, Ireland
Tue 15 13:04
OP16
Oral Posters - Endocrinology 2
Investigating Metastatic Potential in Papillary Thyroid Microcarcinoma (PTMC).
Cork, Ireland
Tara McDonnell
Dublin, Ireland
Tue 15 11:45
OC8
PCOS across lifespan
Oral Presentation: Investigation of the differential impact of oral classic and 11-oxygenated androgen precursor administration on downstream androgen metabolism and insulin sensitivity in women with polycystic ovary syndrome (PCOS)
Dublin, Ireland
Sinead McGlacken-Byrne
London, United Kingdom
Tue 15 12:40
OP13
Oral Posters - Endocrinology 2
A tiered, evidence-based approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency
London, United Kingdom
Anne McGowan
Dublin, Ireland
Tue 15 13:50
HDI2.3
How Do I? 2: Endocrinology
How do I prepare the complex thyrotoxic patient with cardiac disease for surgery?
Dublin, Ireland
Eka Melson
Birmingham, UK
Tue 15 10:45
S10.2
PCOS across lifespan
Expanding diagnostic and biochemical aspects of PCOS
Birmingham, UK
Professor  Alex  Miras
Belfast, Ireland
Mon 14 16:55
S6.2
Obesity
Medical therapies in practice and new developments
Belfast, Ireland
Carla Moran
Dublin, Ireland
Tue 15 10:45
S8.2
Emerging Best Practice in Thyroid Disease
Safe Treatment of Thyroid Disease in Pregnancy
Dublin, Ireland
Dr Helen Murphy
Cambridge, UK
Tue 15 13:45
S11.2
Diabetes in Pregnancy
Technology in pregnancy
Cambridge, UK
Eoin  Noctor
Limerick, Ireland
Mon 14 09:45
HD1.1
How Do I?...1: Diabetes
How do I manage NG feeding-related hyperglycemia
Limerick, Ireland
Finbarr O'Harte
Coleraine, United Kingdom
Mon 14 13:16
OP7
Oral Posters - Diabetes, Obesity and Metabolism 1
Hybrid acylated and non-acylated GLP-1 and apelin receptor co-agonist peptides, show promising acute in vivo anti-hyperglycaemic actions in normal healthy and insulin resistant diet-induced obese mice.
Coleraine, United Kingdom
Professor Sir Stephen O'Rahilly
Cambridge, UK
Tue 15 15:15
PL7
Closing Keynote
Island Hopping: Adventures in Hormones, Metabolism and Behaviour
Cambridge, UK
Michael O'Reilly
Dublin, Ireland
Mon 14 10:10
S1.2
Reining in the Hyperactive Adrenal
Androgen excess
Dublin, Ireland
Professor  Donal O'Shea
Dublin, Ireland
Mon 14 11:50
S2.2
An MDT approach to NETs
Managing secretory NETs
Dublin, Ireland
Prof Kashyap Patel
Exeter, UK
Mon 14 15:05
SK2.2
Genetics in Endocrinology
Phenotype-First or Genotype-First in Genomic Sequencing: What It Means for Clinicians
Exeter, UK
Riccardo Pofi
Oxford, United Kingdom
Mon 14 11:00
OC1
Reining in the Hyperactive Adrenal
Oral Presentation: Differential tissue, and dose-specific adverse effects of exogenous glucocorticoids: implications for clinical practice
Oxford, United Kingdom
Maria L Price
Birmingham, United Kingdom
Mon 14 15:50
OC2
Bone Update
Oral Presentation: The orphan G protein-coupled receptor 35 (GPR35) has an antiresorptive role in primary human osteoclasts
Birmingham, United Kingdom
Samantha Prince
Oxford, United Kingdom
Tue 15 12:48
OP14
Oral Posters - Endocrinology 2
Bone fragility and beyond: prevalence and impact of clinical signs, symptoms, and events in children with osteogenesis imperfecta
Oxford, United Kingdom
Aled Rees
Cardiff University, United Kingdom
Tue 15 11:15
S8.3
Emerging Best Practice in Thyroid Disease
Natural history and management of thyroid hormone resistance-beta: what can real-World data tell us?
Cardiff University, United Kingdom
Julie Refardt
Tue 15 13:20
HDI2.1
How Do I? 2: Endocrinology
How do I use co-peptin and hypertonic saline in AVP disorders?
Professor  Sarah  Richardson
Exeter, UK
Mon 14 18:00
PL4
Diabetes & Metabolism Plenary
Leveraging Insights into Type 1 Diabetes Pathogenesis from Rare Human Pancreas Biobanks
Exeter, UK
Graham Roberts
Waterford, Ireland
Mon 14 10:15
HDI1.3
How Do I?...1: Diabetes
How do I counsel my patient with diabetes on driving regulations
Waterford, Ireland
Dr  Gary  Roulston
Belfast , Ireland
Mon 14 10:30
HDI1.4
How Do I?...1: Diabetes
How do I manage severe hypertriglyceridaemia?
Belfast , Ireland
Dr Sailesh  Sankaranarayanan
Coventry, UK
Mon 14 11:20
T1.1
Navigating UK/Irish Training for International Graduates
International Graduates in the UK health service – facts and figures
Coventry, UK
Ferrah  Shaamile
Dublin, Ireland
Mon 14 11:50
T1.3
Navigating UK/Irish Training for International Graduates
What I wish I’d known - Starting in a new country as an international medical graduate
Dublin, Ireland
Professor Mark Sherlock
Dublin, Ireland
Tue 15 13:45
S12.2
Managing Hypothalamic Syndromes
Water balance
Dublin, Ireland
Professor  Alan  Sinclair
London, UK
Mon 14 11:00
HDI1.5
How Do I?...1: Diabetes
Managing Frailty in Older People with Diabetes
London, UK
Andrew Smyth
Galway, Ireland
Mon 14 17:00
SK3.2
A beginners guide to translational research
How do I design a clinical trial?
Galway, Ireland
Professor Seamus  Sreenan
Galway, Ireland
Tue 15 09:00
PL5
Irish Endocrine Society: McKenna Lecture
When “the best laid schemes of mice and men go oft awry.”
Galway, Ireland
Umasuthan Srirangalingam
London, United Kingdom
Tue 15 14:55
PLO2
Society for Endocrinology Oral Plenary 2
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Enabled Glucocorticoid Dose Reductions in Adults with Classic Congenital Adrenal Hyperplasia: Results from CAHtalyst™
London, United Kingdom
Adam Stevens
Manchester, United Kingdom
Mon 14 16:30
SK3.1
A beginners guide to translational research
Using the integration of omic data to predict and model endocrine action
Manchester, United Kingdom
Andrei Tarasov
Coleraine, United Kingdom
Tue 15 14:35
OC9
Diabetes in Pregnancy
Oral Presentation: Pregnancy induced pancreatic islet expansion is compromised by consumption of cafeteria diet
Coleraine, United Kingdom
Ana Tiganescu
Leeds, United Kingdom
Mon 14 13:08
OP6
Oral Posters - Diabetes, Obesity and Metabolism 1
11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependent
Leeds, United Kingdom
Prof Ian  Turner
Derby, UK
Mon 14 09:45
SK1.1
Approaching Artificial Intelligence with... Intelligence.
How to use AI for academic writing
Derby, UK
Mon 14 10:45
Approaching Artificial Intelligence with... Intelligence.
Open discussion
Derby, UK
Oxford, UK
Professor AJ van der Lely
Erasmus University MC, The Netherlands
Mon 14 14:00
P2
Plenary
Acromegaly is a metabolic disease, far more than a pituitary one
Erasmus University MC, The Netherlands
Professor Jonathan Wadsley
Sheffield, United Kingdom
Mon 14 11:20
S2.1
An MDT approach to NETs
PRRT in treatment algorithims for Gastrenteropancreatic NETs
Sheffield, United Kingdom
Wuyun Zhu
Dublin, Ireland
Mon 14 13:24
OP8
Oral Posters - Diabetes, Obesity and Metabolism 1
Immunophilin Protein FKBPL Regulates Body Weight, Glucose Tolerance, and Islet Morphology in Mice Independent of Food Intake
Dublin, Ireland
Workshop 12
Mon 14 11:20
An MDT approach to NETs
Meeting Room 2
Chair: Ruth Casey (Cambridge, UK) and Anne Marie Hannon (Limerick, Ireland)
Mon 14 11:20
S2.1
An MDT approach to NETs
PRRT in treatment algorithims for Gastrenteropancreatic NETs
Sheffield, United Kingdom
Mon 14 11:50
S2.2
An MDT approach to NETs
Managing secretory NETs
Dublin, Ireland
Mon 14 11:20
Case Reports from submitted abstracts
Hall 2
Chair: Miles Levy (Leicester, United Kingdom) and Kevin Moore (Naas, Ireland)
Mon 14 11:20
CR1
Case Reports from submitted abstracts
Refractory Hypercalcaemia in Advanced Metastatic Pancreatic Neuroendocrine Tumour Controlled on Weekly Denosumab
Sheffield, United Kingdom
Mon 14 11:30
CR2
Case Reports from submitted abstracts
Use of radiofrequency ablation(RFA) in the management of thyroid nodules – a single centre experience
Dublin, Ireland
Mon 14 11:40
CR3
Case Reports from submitted abstracts
Adrenocorticotropin (ACTH) independent Cushing’s Syndrome in pregnancy secondary to overproduction of adrenal luteinizing hormone/human chorionic gonadotropins receptors.
Islamabad, Pakistan
Mon 14 11:50
CR4
Case Reports from submitted abstracts
Pregnancy induction with pulsatile gonadotropin releasing hormone pump (GNRH) therapy in a patient with a KISS1 receptor mutation associated normosmic congenital hypogonadotropic hypogonadism and a very low anti-mullerian hormone: A Case Study
Cork, Ireland
Mon 14 12:00
CR5
Case Reports from submitted abstracts
Gastrointestinal Morbidity Related to Delayed Diagnosis of Pheochromocytoma
Wolverhampton, United Kingdom
Mon 14 12:10
CR6
Case Reports from submitted abstracts
GLP1 receptor agonist and sulphonylurea treatment in KCNJ11 Permanent Neonatal Diabetes
Dublin, Ireland
Mon 14 11:20
Navigating UK/Irish Training for International Graduates
Meeting Room 3
Chair: Fidelma Dunne (Galway, Ireland) and Kashyap Patel (Exeter, United Kingdom)
Mon 14 11:20
T1.1
Navigating UK/Irish Training for International Graduates
International Graduates in the UK health service – facts and figures
Coventry, UK
Mon 14 11:35
T1.2
Navigating UK/Irish Training for International Graduates
How to work effectively in a UK/Irish MDT
London, United Kingdom
Mon 14 11:50
T1.3
Navigating UK/Irish Training for International Graduates
What I wish I’d known - Starting in a new country as an international medical graduate
Dublin, Ireland
Mon 14 12:05
Navigating UK/Irish Training for International Graduates
Panel Discussion
Mon 14 14:35
Bone Update
Meeting Room 3
Chair: Maeve Durkan (Cork, Ireland) and Caroline Gorvin (Birmingham, United Kingdom)
Mon 14 14:35
S3.1
Bone Update
Effects of Exercise on Bone
Loughborough , UK
Mon 14 15:00
S3.2
Bone Update
Gut-Derived Peptides and Bone Disorders in Obesity and Diabetes
Ulster , Ireland
Mon 14 15:25
S3.3
Bone Update
Identification of the genetic determinants and clinical implications of bone marrow adiposity using deep learning in the UK Biobank
Edinburgh , Scotland
Mon 14 15:50
OC2
Bone Update
Oral Presentation: The orphan G protein-coupled receptor 35 (GPR35) has an antiresorptive role in primary human osteoclasts
Birmingham, United Kingdom
Mon 14 14:35
Genetics in Endocrinology
Meeting Room 2
Chair: Paula O Shea (Dublin, Ireland) and Robert Semple (Edinburgh, United Kingdom)
Mon 14 14:35
SK2.1
Genetics in Endocrinology
Hereditary Endocrine neoplasia
Cambridge, United Kingdom
Mon 14 15:05
SK2.2
Genetics in Endocrinology
Phenotype-First or Genotype-First in Genomic Sequencing: What It Means for Clinicians
Exeter, UK
Mon 14 15:35
SK2.3
Genetics in Endocrinology
Hereditary pituitary disease
London, UK
Mon 14 14:35
Type 1 Diabetes
Hall 2
Chair: Neil Black (Londonderry, Ireland) and (Tomas Griffin (Galway, Ireland)
Mon 14 14:35
S4.1
Type 1 Diabetes
Hybrid closed loop technology
Dublin, Republic of Ireland
Mon 14 15:00
S4.2
Type 1 Diabetes
T1DM & Exercise
Exeter, United Kingdom
Mon 14 15:25
S4.3
Type 1 Diabetes
Hypoglycaemia - in the age of CGM
Dublin, Ireland
Mon 14 15:50
OC3
Type 1 Diabetes
Oral Presentation: The relation of microvascular complications to a new interpretation of glycaemic variability from continuous glucose monitoring in people with type 1 diabetes (T1D)
Salford, United Kingdom
Mon 14 16:30
Obesity
Hall 2
Chair: Jean O'Connell (Dublin, Ireland) and Sam Lockhart (Cambridge, United Kingdom)
Mon 14 16:30
S6.1
Obesity
Metabolic Surgery which to choose and new developments
Dublin, Ireland
Mon 14 16:55
S6.2
Obesity
Medical therapies in practice and new developments
Belfast, Ireland
Mon 14 17:20
OC4
Obesity
Oral Presentation: Selective sweep mapping identifies obesity candidate mutations in Labrador Retrievers
Cambridge, United Kingdom
Mon 14 16:30
A beginners guide to translational research
Meeting Room 2
Chair: Diarmuid Smith (Dublin, Ireland) and Waljit Dhillo (London, United Kingdom)
Mon 14 16:30
SK3.1
A beginners guide to translational research
Using the integration of omic data to predict and model endocrine action
Manchester, United Kingdom
Mon 14 17:00
SK3.2
A beginners guide to translational research
How do I design a clinical trial?
Galway, Ireland
Mon 14 16:30
Tricky Pituitary Cases
Meeting Room 3
Chair: Domhnall O'Halloran (Cork, Ireland) and Bahram Jafar-Mohammadi (Oxford, United Kingdom)
Mon 14 16:30
S7.1
Tricky Pituitary Cases
Other sellar tumours
London, UK
Mon 14 16:55
S7.2
Tricky Pituitary Cases
Cyclical Cushing's
Tartu, Estonia
Mon 14 17:20
OC5
Tricky Pituitary Cases
Oral Presentation: Multiplex Immunofluorescence Identifies Novel Role for STING Upregulation in Pituitary Neuroendocrine Tumours
Belfast, United Kingdom
Tue 15 13:20
How Do I? 2: Endocrinology
Hall 2
Chair: Amar Agha (Dublin, Ireland) and Victoria Stokes (Cambridge, United Kingdom)
Tue 15 13:20
HDI2.1
How Do I? 2: Endocrinology
How do I use co-peptin and hypertonic saline in AVP disorders?
Tue 15 13:35
HDI2.2
How Do I? 2: Endocrinology
How do I treat psychiatric complications of Cushing's syndrome?
Birmingham, UK
Tue 15 13:50
HDI2.3
How Do I? 2: Endocrinology
How do I prepare the complex thyrotoxic patient with cardiac disease for surgery?
Dublin, Ireland
Tue 15 14:05
HDI2.4
How Do I? 2: Endocrinology
How do I medically manage primary hyperaldosteronism?
Cambridge, UK
Tue 15 14:20
HDI2.5
How Do I? 2: Endocrinology
How do I manage menopause without HRT?
London, UK
Tue 15 14:35
HDI2.6
How Do I? 2: Endocrinology
How do I select and prepare a patient for parathyroid surgery?
Galway, Ireland
Tue 15 13:20
Managing Hypothalamic Syndromes
Meeting Room 2
Chair: Nigel Glynn (Dublin, Ireland) and Andrew Lansdown (Cardiff, United Kingdom)
Tue 15 13:20
S12.1
Managing Hypothalamic Syndromes
Disordered sleep
Dublin, Ireland
Tue 15 13:45
S12.2
Managing Hypothalamic Syndromes
Water balance
Dublin, Ireland
Tue 15 14:10
S12.3
Managing Hypothalamic Syndromes
Unravelling Hypothalamic Obesity: Navigating the Challenges and Exploring Future Solutions
Sheffield, UK
Tue 15 14:35
OC10
Managing Hypothalamic Syndromes
Oral Presentation: Gonadotropin Rise Following Intranasal Kisspeptin Administration Is Increased in Women With Hypothalamic Amenorrhoea Compared to Healthy Women
London, United Kingdom
Tue 15 13:20
Diabetes in Pregnancy
Meeting Room 3
Chair: Christine Newman (Galway, Ireland) and Kleopatra Alexiadou (London, United Kingdom)
Tue 15 13:20
S11.1
Diabetes in Pregnancy
T2 in pregnancy
Aarhus , Denmark
Tue 15 13:45
S11.2
Diabetes in Pregnancy
Technology in pregnancy
Cambridge, UK
Tue 15 14:10
S11.3
Diabetes in Pregnancy
Metformin in pregnancy complicated by diabetes
Galway, Ireland
Tue 15 14:35
OC9
Diabetes in Pregnancy
Oral Presentation: Pregnancy induced pancreatic islet expansion is compromised by consumption of cafeteria diet
Coleraine, United Kingdom
Oral 4
Mon 14 12:25
Oral Posters - Endocrinology 1
Hall 2
Chair: Mark Hannon (Bantry, Ireland) and Maralyn Druce (London, United Kingdom)
Mon 14 12:25
OP1
Oral Posters - Endocrinology 1
Gene methylation status in delayed puberty
London, United Kingdom
Mon 14 12:33
OP2
Oral Posters - Endocrinology 1
Audit on the Management of Cystic Prolactinomas
Dublin, Ireland
Mon 14 12:41
OP3
Oral Posters - Endocrinology 1
Immunomodulation of Severe Graves' Disease: Graves'-Plasma Cell Depletion (PCD) Trial
Newcastle, United Kingdom
Mon 14 12:49
OP4
Oral Posters - Endocrinology 1
GIP receptor agonist and antagonist alter testicular morphology and sperm parameters in high-fat diet fed obese mice.
Coleraine, United Kingdom
Mon 14 13:00
Oral Posters - Diabetes, Obesity and Metabolism 1
Hall 2
Chair: Oratile Kgosidialwa (Cork, Ireland) and Robert Murray (Leeds, United Kingdom)
Mon 14 13:00
OP5
Oral Posters - Diabetes, Obesity and Metabolism 1
The role of soluble epoxide hydrolase in metabolic-associated fatty liver disease.
Taipei, Taiwan
Mon 14 13:08
OP6
Oral Posters - Diabetes, Obesity and Metabolism 1
11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependent
Leeds, United Kingdom
Mon 14 13:16
OP7
Oral Posters - Diabetes, Obesity and Metabolism 1
Hybrid acylated and non-acylated GLP-1 and apelin receptor co-agonist peptides, show promising acute in vivo anti-hyperglycaemic actions in normal healthy and insulin resistant diet-induced obese mice.
Coleraine, United Kingdom
Mon 14 13:24
OP8
Oral Posters - Diabetes, Obesity and Metabolism 1
Immunophilin Protein FKBPL Regulates Body Weight, Glucose Tolerance, and Islet Morphology in Mice Independent of Food Intake
Dublin, Ireland
Tue 15 12:05
Oral Posters - Diabetes, Obesity and Metabolism 2
Hall 2
Chair: Robert McEvoy (Galway, Ireland) and Maryjane Brassill (Tipperary, Ireland)
Tue 15 12:05
OP9
Oral Posters - Diabetes, Obesity and Metabolism 2
The impact of social deprivation on development and progression of diabetic kidney disease- a retrospective cohort study
Galway, Ireland
Tue 15 12:13
Oral Posters - Diabetes, Obesity and Metabolism 2
Access to Psychological Medicine Services improves outcomes in vulnerable patients with diabetes
Dublin, Ireland
Tue 15 12:21
OP11
Oral Posters - Diabetes, Obesity and Metabolism 2
Associations between Fear of Hypoglycaemia and Step-Count Among Adults with Type 1 Diabetes and Insulin-Treated Type 2 Diabetes: Findings from the Hypo-METRICS Study
Belfast, United Kingdom
Tue 15 12:29
OP12
Oral Posters - Diabetes, Obesity and Metabolism 2
Real-world outcomes of smart insulin pens in adults with diabetes mellitus attending an Irish tertiary hospital
Dublin, Ireland
Tue 15 12:40
Oral Posters - Endocrinology 2
Hall 2
Chair: Ronan Canavan (Dublin, Ireland) and Jeremy Turner (Norfolk, United Kingdom)
Tue 15 12:40
OP13
Oral Posters - Endocrinology 2
A tiered, evidence-based approach to exome sequencing analysis in early-onset Primary Ovarian Insufficiency
London, United Kingdom
Tue 15 12:48
OP14
Oral Posters - Endocrinology 2
Bone fragility and beyond: prevalence and impact of clinical signs, symptoms, and events in children with osteogenesis imperfecta
Oxford, United Kingdom
Tue 15 12:56
OP15
Oral Posters - Endocrinology 2
A UK single-centre experience of the use of osilodrostat in pituitary MRI negative Cushing’s Disease
London, United Kingdom
Tue 15 13:04
OP16
Oral Posters - Endocrinology 2
Investigating Metastatic Potential in Papillary Thyroid Microcarcinoma (PTMC).
Cork, Ireland
Expert 0
Plenary 9
Mon 14 09:00
Opening Keynote
Hall 2
Chair: Simon Pearce (Newcastle, United Kingdom)
Mon 14 09:00
PL1
Opening Keynote
Optimising Management of Adrenal Insufficiency
Bergen, Norway
Mon 14 13:40
Society for Endocrinology Oral Plenary 1
Hall 2
Chair: Mark Gurnell (Cambridge, United Kingdom) and Fidelma Dunne (Galway, Ireland)
Mon 14 13:40
PLO1
Society for Endocrinology Oral Plenary 1
Damaging mutations in LXRα uncouple lipogenesis from hepatotoxicity and implicate hepatic cholesterol sensing in human liver health
Cambridge, United Kingdom
Mon 14 14:00
Plenary
Hall 2
Chair: Mark Gurnell (Cambridge, United Kingdom)
Mon 14 14:00
P2
Plenary
Acromegaly is a metabolic disease, far more than a pituitary one
Erasmus University MC, The Netherlands
Mon 14 17:30
Irish Endocrine Society: Hadden Lecture
Hall 2
Chair: Fidelma Dunne (Galway, Ireland)
Mon 14 17:30
PL3
Irish Endocrine Society: Hadden Lecture
The endocrinologist’s role along the patient cancer journey – from pre-diagnosis to survival and vitality beyond
London, UK
Mon 14 18:00
Diabetes & Metabolism Plenary
Hall 2
Chair: Ridhwaan Salemohamed (Galway, Ireland)
Mon 14 18:00
PL4
Diabetes & Metabolism Plenary
Leveraging Insights into Type 1 Diabetes Pathogenesis from Rare Human Pancreas Biobanks
Exeter, UK
Tue 15 09:00
Irish Endocrine Society: McKenna Lecture
Hall 2
Chair: Fidelma Dunne (Galway, Ireland)
Tue 15 09:00
PL5
Irish Endocrine Society: McKenna Lecture
When “the best laid schemes of mice and men go oft awry.”
Galway, Ireland
Tue 15 09:30
Endocrinology Plenary
Hall 2
Chair: Rachel Crowley (Dublin, Ireland)
Tue 15 09:30
PL6
Endocrinology Plenary
State of the Art in Osteoporosis
Aarhus, Denmark
Tue 15 14:55
Society for Endocrinology Oral Plenary 2
Hall 2
Chair: Robert Semple (Edinburgh, United Kingdom) and Fidelma Dunne (Galway, Ireland)
Tue 15 14:55
PLO2
Society for Endocrinology Oral Plenary 2
Crinecerfont, a Corticotropin-Releasing Factor Type 1 Receptor (CRF1) Antagonist, Reduced Excess Adrenal Androgens and Enabled Glucocorticoid Dose Reductions in Adults with Classic Congenital Adrenal Hyperplasia: Results from CAHtalyst™
London, United Kingdom
Tue 15 15:15
Closing Keynote
Hall 2
Chair: Robert Semple (Edinburgh, United Kingdom)
Tue 15 15:15
PL7
Closing Keynote
Island Hopping: Adventures in Hormones, Metabolism and Behaviour
Cambridge, UK
Catering and Social 6
Mon 14 12:20
Lunch, Exhibition and Posters
Hall 1
Mon 14 16:05
Tea and Coffee
Hall 1
Mon 14 18:30
Networking Reception
Hall 1
Mon 14 19:30
Conference Dinner
Tue 15 10:00
Tea and Coffee
Hall 1
Tue 15 12:00
Lunch, Exhibition and Posters
Hall 1
Nurse 0
Other 8
Mon 14 08:50
Welcome
Hall 2
Mon 14 08:50
Welcome
Welcome
Mon 14 12:35
INDUSTRY-SPONSORED SATELLITE SYMPOSIA 1 - (Please see Sponsored Satellite Symposia programme for more information)
Meeting Room 2
Mon 14 12:35
INDUSTRY-SPONSORED SATELLITE SYMPOSIA 2 - (Please see Sponsored Satellite Symposia programme for more information)
Meeting Room 3
Tue 15 08:00
Irish Endocrine Society: AGM
Meeting Room 2
Tue 15 08:00
Society for Endocrinology: AGM
Meeting Room 3
Tue 15 12:15
INDUSTRY-SPONSORED SATELLITE SYMPOSIA 3 - (Please see Sponsored Satellite Symposia programme for more information)
Meeting Room 2
Tue 15 12:15
INDUSTRY-SPONSORED SATELLITE SYMPOSIA 4 - (Please see Sponsored Satellite Symposia programme for more information)
Meeting Room 3
Tue 15 15:55
Prizes and Close
Hall 2
Chair: Márta Korbonits (London, UK) and Fidelma Dunne (Galway, Ireland)
Symposium 6
Mon 14 09:45
Approaching Artificial Intelligence with... Intelligence.
Meeting Room 2
Chair: Kevin Murphy (London, United Kingdom) and Matthew Murphy (Cork, Ireland)
Mon 14 09:45
SK1.1
Approaching Artificial Intelligence with... Intelligence.
How to use AI for academic writing
Derby, UK
Mon 14 10:15
SK1.2
Approaching Artificial Intelligence with... Intelligence.
Using AI to predict bone fractures
Oxford, UK
Mon 14 10:45
Approaching Artificial Intelligence with... Intelligence.
Open discussion
Derby, UK
Oxford, UK
Mon 14 09:45
Reining in the Hyperactive Adrenal
Meeting Room 3
Chair: Conall Dennedy (Galway, Ireland) and Antoinette Tuthill (Cork, Ireland)
Mon 14 09:45
S1.1
Reining in the Hyperactive Adrenal
Mild autonomous cortisol secretion
Sheffield, UK
Mon 14 10:10
S1.2
Reining in the Hyperactive Adrenal
Androgen excess
Dublin, Ireland
Mon 14 10:35
S1.3
Reining in the Hyperactive Adrenal
The diagnostic approach to challenging adrenal lesions
Glasgow, UK
Mon 14 11:00
OC1
Reining in the Hyperactive Adrenal
Oral Presentation: Differential tissue, and dose-specific adverse effects of exogenous glucocorticoids: implications for clinical practice
Oxford, United Kingdom
Mon 14 09:45
How Do I?...1: Diabetes
Hall 2
Chair: Helen Wallace (Belfast, Ireland) and Mairead Crowley (Dublin, Ireland)
Mon 14 09:45
HD1.1
How Do I?...1: Diabetes
How do I manage NG feeding-related hyperglycemia
Limerick, Ireland
Mon 14 10:00
HDI1.2
How Do I?...1: Diabetes
How do I manage diabetes across time zones?
Galway, Ireland
Mon 14 10:15
HDI1.3
How Do I?...1: Diabetes
How do I counsel my patient with diabetes on driving regulations
Waterford, Ireland
Mon 14 10:30
HDI1.4
How Do I?...1: Diabetes
How do I manage severe hypertriglyceridaemia?
Belfast , Ireland
Mon 14 10:45
HDI1.6
How Do I?...1: Diabetes
How do I approach diabetes distress?
Belfast , Ireland
Mon 14 11:00
HDI1.5
How Do I?...1: Diabetes
Managing Frailty in Older People with Diabetes
London, UK
Tue 15 10:15
Emerging Best Practice in Thyroid Disease
Meeting Room 3
Chair: Elizabeth Brosnan (Castlebar, Ireland) and Bijay Vaidya (Exeter, United Kingdom)
Tue 15 10:15
S8.1
Emerging Best Practice in Thyroid Disease
Current Management of Low Risk Thyroid Cancer
Birmingham, UK
Tue 15 10:45
S8.2
Emerging Best Practice in Thyroid Disease
Safe Treatment of Thyroid Disease in Pregnancy
Dublin, Ireland
Tue 15 11:15
S8.3
Emerging Best Practice in Thyroid Disease
Natural history and management of thyroid hormone resistance-beta: what can real-World data tell us?
Cardiff University, United Kingdom
Tue 15 11:45
OC7
Emerging Best Practice in Thyroid Disease
Oral Presentation: Thyroid Hormone analogue (Triac) therapy in Resistance to Thyroid Hormone beta reduces hyperthyroid symptoms, lowers circulating thyroid hormones and metabolic rate effectively, without adverse effects.
Dublin, Ireland
Tue 15 10:15
PCOS across lifespan
Meeting Room 2
Chair: Lisa Owens (Dublin, Ireland) and Punith Kempegowda (Birmingham, United Kingdom)
Tue 15 10:15
S10.1
PCOS across lifespan
Metabolic and Cardiovascular consequences (North Finland Cohort)
Oulu, Finland
Tue 15 10:45
S10.2
PCOS across lifespan
Expanding diagnostic and biochemical aspects of PCOS
Birmingham, UK
Tue 15 11:15
S10.3
PCOS across lifespan
Fertility treatment and pre-conception optimisation
Dublin, Ireland
Tue 15 11:45
OC8
PCOS across lifespan
Oral Presentation: Investigation of the differential impact of oral classic and 11-oxygenated androgen precursor administration on downstream androgen metabolism and insulin sensitivity in women with polycystic ovary syndrome (PCOS)
Dublin, Ireland
Tue 15 10:15
Type 2 Diabetes
Hall 2
Chair: Eoin Noctor (Limerick, Ireland) and Chioma Izzi-Engbeaya (London, United Kingdom)
Tue 15 10:15
S9.1
Type 2 Diabetes
Exercise and type 2 diabetes: can we predict changes in glycaemic control and weight during training?
Glasgow , Scotland
Tue 15 10:45
S9.2
Type 2 Diabetes
Community Diabetes - setting up a service/ Value based health care
Belfast, Ireland
Tue 15 11:15
S9.3
Type 2 Diabetes
Using healthcare data to improve practice and yield disease insights
Edinburgh, Scotland
Tue 15 11:45
OC6
Type 2 Diabetes
Oral Presentation: Once-daily oral administration of gpr55 agonist ml-184 has direct and indirect benefits on β-cell and gastrointestinal health in obese-diabetic mice
Coleraine, United Kingdom
No Session Type 0

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract